Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 7 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1572904 |
| 301 | 3 | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY//LEVOSIMENDAN//PHARMACOLOGY & PHARMACY | 41522 |
| 980 | 2 | NICORANDIL//CALCIUM ANTAGONISTS//CALCIUM CHANNEL BLOCKERS | 10891 |
| 25379 | 1 | ISRADIPINE//CAS 75695 93 1//LOMIR SROR | 306 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | ISRADIPINE | authKW | 2098491 | 27% | 25% | 82 |
| 2 | CAS 75695 93 1 | authKW | 429147 | 2% | 83% | 5 |
| 3 | LOMIR SROR | authKW | 205991 | 1% | 100% | 2 |
| 4 | GATED RADIONUCLIDE ANGIOGRAPHY | authKW | 137326 | 1% | 67% | 2 |
| 5 | ACE INHIBITORS AND DIURETICS | authKW | 102996 | 0% | 100% | 1 |
| 6 | ACTIVE FRACTION OF AGELANTHUS DODONEIFOLIUS | authKW | 102996 | 0% | 100% | 1 |
| 7 | ANTIVASOCONSTRICTOR EFFECTS | authKW | 102996 | 0% | 100% | 1 |
| 8 | BENEFITS OF ANTIHYPERTENSION THERAPY | authKW | 102996 | 0% | 100% | 1 |
| 9 | CALCIUM ANTAGONIST HEMODYNAMIC EFFECTS | authKW | 102996 | 0% | 100% | 1 |
| 10 | CALCIUM ANTAGONISTS EXOGENOUS | authKW | 102996 | 0% | 100% | 1 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Cardiac & Cardiovascular System | 2389 | 35% | 0% | 107 |
| 2 | Pharmacology & Pharmacy | 2140 | 49% | 0% | 149 |
| 3 | Peripheral Vascular Diseases | 1100 | 18% | 0% | 55 |
| 4 | Medicine, General & Internal | 125 | 11% | 0% | 33 |
| 5 | Toxicology | 50 | 5% | 0% | 14 |
| 6 | Anesthesiology | 14 | 2% | 0% | 5 |
| 7 | Medicine, Research & Experimental | 12 | 4% | 0% | 11 |
| 8 | Chemistry, Medicinal | 8 | 2% | 0% | 7 |
| 9 | Urology & Nephrology | 3 | 2% | 0% | 5 |
| 10 | Integrative & Complementary Medicine | 1 | 0% | 0% | 1 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | HYPERTENS CLIN PHARMACOL SECT | 102996 | 0% | 100% | 1 |
| 2 | MED HAACHTSESTEENWEG CHAUSEE HAECHT 226 | 102996 | 0% | 100% | 1 |
| 3 | MED PHARMACOL GIVEN BLDG | 102996 | 0% | 100% | 1 |
| 4 | MED RENAL DISORDERS | 102996 | 0% | 100% | 1 |
| 5 | S TEXAS ADDICT TECHNOL | 51497 | 0% | 50% | 1 |
| 6 | CNRS UMR 7285 IC2MP | 25747 | 0% | 25% | 1 |
| 7 | SUPERACID GRP | 25747 | 0% | 25% | 1 |
| 8 | MALMO GEN HOSP ENDOCRINOL | 12873 | 0% | 13% | 1 |
| 9 | MALMO GEN HOSP MED | 11442 | 0% | 11% | 1 |
| 10 | PRACT ARTS EDUC | 10298 | 0% | 10% | 1 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | 37122 | 21% | 1% | 63 |
| 2 | AMERICAN JOURNAL OF HYPERTENSION | 19793 | 11% | 1% | 34 |
| 3 | AMERICAN JOURNAL OF MEDICINE | 3278 | 6% | 0% | 19 |
| 4 | DRUGS | 2168 | 4% | 0% | 11 |
| 5 | EXPERIMENTELLE PATHOLOGIE | 1744 | 0% | 2% | 1 |
| 6 | CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL | 1730 | 3% | 0% | 9 |
| 7 | EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1426 | 3% | 0% | 10 |
| 8 | JOURNAL OF HUMAN HYPERTENSION | 1339 | 2% | 0% | 7 |
| 9 | AMERICAN JOURNAL OF CARDIOLOGY | 959 | 5% | 0% | 16 |
| 10 | HERZ KREISLAUF | 944 | 1% | 0% | 3 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |